CV SciencesCVSI +9.09% Days Payable is 59.34 as of Mar. 2026, which is 3% below its 10-year median of 60.90. The stock has 2 warning signs investors should review. Among 920 Drug Manufacturers companies, CV Sciences ranks worse than 62.61% on this metric.
The historical rank and industry rank for CV Sciences's Days Payable or its related term are showing as below:
CVSI'
s Days Payable Range Over the Past 10 Years
Min: 24.43 Med: 60.9 Max: 93.98
Current: 68.13
During the past 13 years, CV Sciences's highest Days Payable was 93.98. The lowest was 24.43. And the median was 60.90.
CVSI's Days Payable is ranked worse than 62.61% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs CVSI: 68.13
CV Sciences's Days Payable
declined
from Mar. 2025 (80.12) to Mar. 2026 (59.34).
It may suggest that CV Sciencesaccelerated paying its suppliers.
CV Sciences Days Payable Related Terms
CV Sciences Days Payable Historical Data
* Premium members only.
The historical data trend for CV Sciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CV Sciences Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CV Sciences's Days Payable distribution charts can be found below:
* The bar in red indicates where CV Sciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CV Sciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CV Sciences (CVSI) has a Days Payable of 59.34 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CV Sciences and its competitors. This is near median its historical median of 60.90. Over the past decade, CV Sciences' Days Payable has ranged from 24.43 to 93.98. According to the industry distribution chart, CV Sciences ranks #576 out of 920 companies in the Drug Manufacturers industry, placing it in the top 62.6%.
Is CV Sciences' Days Payable too high?
CV Sciences' current Days Payable of 59.34 is near median its 10-year median of 60.90. Over the past 10 years, this metric has ranged from a low of 24.43 to a high of 93.98. The Drug Manufacturers industry median Days Payable is 90.84. CV Sciences' value of 59.34 is 34.7% below this industry median. Based on the distribution chart, CV Sciences ranks #576 out of 920 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does CV Sciences' Days Payable compare to INM and GELS?
According to the Drug Manufacturers industry distribution chart, CV Sciences ranks #576 out of 920 companies for Days Payable. This places CV Sciences in the lower half of its industry. The industry median Days Payable is 90.84. CV Sciences' value of 59.34 is 34.7% below this benchmark. Historically, CV Sciences' own Days Payable has ranged from 24.43 to 93.98 over the past decade. While the company's 10-year median is 60.90 vs. the industry median of 90.84, CV Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CV Sciences's current Days Payable of 59.34 is 34.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CV Sciences and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CV Sciences's current Days Payable is 59.34, which is near median its own 10-year median of 60.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CV Sciences stock overvalued right now?
Based on GuruFocus' analysis, CV Sciences (CVSI) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 20% below its estimated fair value. The current Days Payable is 59.34, which is near median its 10-year median of 60.90 and 34.7% below the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CV Sciences (CVSI), the current Days Payable is 59.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CV Sciences Inc is a consumer wellness company specializing in nutraceuticals and plant-based foods products. It develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The company sells its products under tradenames, such as +PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox. The company's products are sold in a variety of market sectors, including nutraceutical, beauty care, and specialty foods. The company has one operating segment, which is the business of hemp-based CBD wellness products. Geographically, all of the company's revenue is generated from United States. The company also operates a drug development program focused on developing and commercializing CBD-based novel therapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSI has been successfully added to your 